Biotech acquisitions by big pharma: why and what is next-Reference-Cited by-同舟云学术

Biotech acquisitions by big pharma: why and what is next

Published:2009-09 Issue:17-18 Volume:14 Page:818-821
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Malik Nafees N.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference27 articles.

1. Intelligence.360 – Global Pharmaceutical Perspectives 2007;IMS Health,2008

2. Beyond Borders: Global Biotechnology Report 2008;Ernst & Young,2008

3. Roth, G.Y. et al. (2006) Top 10 Biopharma Companies Report. Contract Pharma July/August. Available at URL: http://www.contractpharma.com/articles/2006/07/top-biopharma-companies-report

4. Roche and Genentech reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation;Roche,2009

5. Merck KGaA pays $13.3 billion for Serono, including US headquarters in Rockland;Heuser;The Boston Globe,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partnership agreements for regenerative medicines: a database analysis and implications for future innovation;Regenerative Medicine;2021-08

2. SETTING THE “RIGHT” GOAL: POST M&A INNOVATION PERFORMANCE AND GOAL ORIENTATION;Business: Theory and Practice;2020-09-08

3. Biopharmaceutical development, production, and quality;New and Future Developments in Microbial Biotechnology and Bioengineering;2020

4. Measuring the Efficiency of U.S. Pharmaceutical Companies Based on Open Innovation Types;Journal of Open Innovation: Technology, Market, and Complexity;2018-08-08

5. Closing Distances Between Academia and Market;Comprehensive Medicinal Chemistry III;2017